Cris Bergerot, PhD
LightNews LightNews
banner
crisbergerot.bsky.social
Cris Bergerot, PhD
@crisbergerot.bsky.social
500 followers 200 following 97 posts
Advancing oncology care through research, innovation, and multidisciplinary collaboration. Passionate about patient-centered solutions, PROs, HRQOL, and evidence-based practices, w a focus on #GUOnc, #GeriOnc & #PallOnc

#ASCO25 FCOI: http://bit.ly/344gKxq
Posts Replies Media Videos
Pinned
crisbergerot.bsky.social
Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28
🚨New @ascocancer.bsky.social Guideline Alert! 🌍
Honored to have worked alongside #EnriqueSoto & cols in developing this guideline

Check out the latest recommendations on GA, designed to improve care worldwide

📄Full guideline ascopubs.org/doi/pdf/10.1...

🎙️Don’t miss the accompanying podcast!
Reposted by Cris Bergerot, PhD
pallonccop.bsky.social
Join us #tomorrow 4p EST to hear Dr Tamryn Gray speak about #family centered caregiving as well as an update in #policy through the implementation of the #CARE act. DM for a link. #pallonc

@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
November 18, 2025 at 9:08 AM
Reposted by Cris Bergerot, PhD
ipospsychooncol.bsky.social
Day one of #COSAIPOS2025 is almost done! What a great day.

Are you here? Make sure you come visit the IPOS and COSA lounge!
November 12, 2025 at 7:10 AM
Reposted by Cris Bergerot, PhD
brueraeduardo.bsky.social
A letter to the editor discusses use of Olanzapine in cancer-associated cachexia, reporting possible short-term improvements in weight/appetite but raising uncertainty about long-term efficacy, risks and optimal patient selection.

pubmed.ncbi.nlm.nih.gov/41213247/
Letter to the Editor: Olanzapine for Cachexia-Short-Term Benefit, Long-Term Questions - PubMed
Letter to the Editor: Olanzapine for Cachexia-Short-Term Benefit, Long-Term Questions
pubmed.ncbi.nlm.nih.gov
November 13, 2025 at 7:26 AM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
Voting in the ASCO Election is open now until December 8! Meet the candidate for President-Elect, Deborah Schrag, MD, MPH, FASCO.

Learn more about Dr. Schrag and make your voice heard at: brnw.ch/21wXn9K
November 10, 2025 at 9:09 PM
Reposted by Cris Bergerot, PhD
funchainmd.bsky.social
To be in the company of @mikkaelsekeres.bsky.social @crisbergerot.bsky.social is wild! Congrats to my fellow Fellows. I am so honored to be in your company and to be recognized by @ASCO
ascocancer.bsky.social American Society of Clinical Oncology @ascocancer.bsky.social · 22d
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.

Learn more about FASCO distinction: brnw.ch/21wX0Hi
October 29, 2025 at 6:12 AM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.

Learn more about FASCO distinction: brnw.ch/21wX0Hi
October 28, 2025 at 8:29 PM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
💚 As we close out #ASCOQLTY25, we are grateful to all of our attendees, in person and online, for being a part of the conversation as we work together to make progress in the quality, safety, and efficiency of #CancerCare delivery.
October 11, 2025 at 9:37 PM
Reposted by Cris Bergerot, PhD
pallonccop.bsky.social
Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect
@ryannipp.bsky.social

DM for the link or to be added to our mailing list.
@realbowtiedoc.bsky.social
@crisbergerot.bsky.social
@ericroeland.bsky.social
@fionnualacrowley.bsky.social

#pallonc
October 21, 2025 at 3:55 PM
Reposted by Cris Bergerot, PhD
clarinetsax.bsky.social
For #NSCLC patients, socio-demographics better predict distress levels than metastatic status—challenging common assumptions in psych-oncology.

#ASCOQLTY25 #LungCancer #PsychosocialSupport
www.CancerSupportCommunity.org

Poster:
www.cancersupportcommunity.org/sites/defaul...
October 11, 2025 at 5:14 PM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them!

@fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social
October 11, 2025 at 2:33 PM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
Happening now at #ASCOQLTY25: Rapid Oral Abstract Session A ▶️ meetings.asco.org/2025-asco-qu...

@crisbergerot.bsky.social @ryanhuey.bsky.social @christopherrios.bsky.social
October 10, 2025 at 3:31 PM
Reposted by Cris Bergerot, PhD
jrgralow.bsky.social
Great energy & dialogue in NYC this week during UN General Assembly & today’s High-level meeting on Non-Communicable Diseases & Mental Health. Working in collaboration we can (and must) accelerate efforts to improve outcomes in cancer & all NCDs globally. #UNGA2025 @ascocancer.bsky.social
September 25, 2025 at 3:37 PM
Reposted by Cris Bergerot, PhD
pallonccop.bsky.social
Mark your calendars for the year. DM to be added to our mailing list and never miss a meeting:

@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
September 26, 2025 at 1:13 PM
Reposted by Cris Bergerot, PhD
pallonccop.bsky.social
Join us this evening 4pm EST!

@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social
September 25, 2025 at 5:27 PM
Reposted by Cris Bergerot, PhD
pallonccop.bsky.social
This Thursday!! Join us for our kick-off meeting with our leaders @crisbergerot.bsky.social and @realbowtiedoc.bsky.social. DM for link

@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
September 22, 2025 at 9:03 AM
Reposted by Cris Bergerot, PhD
realbowtiedoc.bsky.social
The legendary @brueraeduardo.bsky.social discussing #survonc with long term #chronic toxicity and multi-dimensional #suffering. Love the #pallonc integration. #SuppOnc treats all patients and their suffering.
September 20, 2025 at 1:37 AM
Reposted by Cris Bergerot, PhD
pallonccop.bsky.social
Yes it's that time of year again! #PallOncCoP is launching its Webinar Kick Off event in 2 weeks Sept 25th 4-5p EST. DM for a link or send your email to pallonccop@gmail.com to be added to the listserv.

See you soon! #pallonc #supponc
@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
September 15, 2025 at 11:40 PM
Reposted by Cris Bergerot, PhD
realbowtiedoc.bsky.social
My favorite community connection every month! So glad we are restarting. Join my co-champ 🏆
@crisbergerot.bsky.social and I as we set the stage for
@pallonccop.bsky.social 25-26. An amazing lineup of speakers. Join us Sept 25th
September 15, 2025 at 11:43 PM
Reposted by Cris Bergerot, PhD
realbowtiedoc.bsky.social
#GI26 is the perfect conference to showcase the best of #GIonc Don't miss out submit today!
@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@oncbrothers.bsky.social
ascocancer.bsky.social American Society of Clinical Oncology @ascocancer.bsky.social · Sep 5
Hey, don’t forget to submit that #GI26 abstract! It’s your time to shine and help shape the future of GI cancer care with your #gicsm study in progress or a late-stage clinical trial.

Abstracts are due Sept. 9 at 11:59 p.m. (ET). Learn more: brnw.ch/21wVvcH
September 7, 2025 at 11:14 PM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
Investing in research today prevents suffering tomorrow & ensures our national scientific standing. We cannot turn away from millions counting on American ingenuity to live healthier lives. #ASCOAdvocacy #SaveResearchStopCancer

Take action with us: brnw.ch/21wVvP3
September 5, 2025 at 6:29 PM
Reposted by Cris Bergerot, PhD
craiggedye.bsky.social
Fantastic to have this critical advice for older people with cancer - thank you @crisbergerot.bsky.social @bogda-koczwara.bsky.social and team
crisbergerot.bsky.social Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28
🚨New @ascocancer.bsky.social Guideline Alert! 🌍
Honored to have worked alongside #EnriqueSoto & cols in developing this guideline

Check out the latest recommendations on GA, designed to improve care worldwide

📄Full guideline ascopubs.org/doi/pdf/10.1...

🎙️Don’t miss the accompanying podcast!
September 4, 2025 at 9:14 PM
crisbergerot.bsky.social
Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care

Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social
September 3, 2025 at 11:17 PM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
Showcase your expertise to leaders in the international GU scientific community & generate fresh collaborations by sharing your research at #GU26—The Place to Be Heard.

Submit an abstract to our 2026 ASCO Genitourinary Symposium by the Oct 21 deadline: brnw.ch/21wVrHY
September 3, 2025 at 8:05 PM
Reposted by Cris Bergerot, PhD
ascocancer.bsky.social
We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25.

Registration is still open: brnw.ch/21wVoQS
September 2, 2025 at 2:02 PM
Reposted by Cris Bergerot, PhD
fumikochino.bsky.social
⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon!

Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery.

📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)
Registration Details - ASCO
Early Registration Deadline: Wednesday, September 3, 2025 at 11:59 PM (ET)
www.asco.org
August 25, 2025 at 6:11 PM